BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/29/2021 8:35:47 AM | Browse: 452 | Download: 815
 |
Received |
|
2021-01-18 11:55 |
|
Peer-Review Started |
|
2021-01-18 11:57 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-02-10 12:42 |
|
Revised |
|
2021-02-11 07:51 |
|
Second Decision |
|
2021-03-16 12:09 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-03-17 05:54 |
|
Articles in Press |
|
2021-03-17 05:54 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-03-29 13:03 |
|
Typeset the Manuscript |
|
2021-04-08 04:16 |
|
Publish the Manuscript Online |
|
2021-04-29 08:35 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Prediction models for the development of hepatocellular carcinoma in chronic hepatitis B patients
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jiang Guo and Xue-Song Gao |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Science and Technology Major Project of China |
2018ZX10715-005-003-002 |
| Health Development and Scientific Research in the Capital |
2018-1-2181 |
|
| Corresponding Author |
Xue-Song Gao, MD, PhD, Chief Physician, Department of General Medicine, Beijing Ditan Hospital, Capital Medical University, No. 8 Jingshundong Street, Chaoyang District, Beijing 100015, China. gaoxuesong@ccmu.edu.cn |
| Key Words |
Antiviral agents; Hepatitis B virus; Hepatocellular carcinoma; Liver cirrhosis; Risk factors; Proportional hazards models |
| Core Tip |
Risk scores are useful in estimating hepatocellular carcinoma (HCC) risk in chronic hepatitis B (CHB) patients. While antiviral therapy does not eliminate the risk of hepatitis B virus (HBV)-related HCC, it modifies the natural disease course to reduce the HCC risk. CU-HCC (Chinese University-HCC), GAG-HCC (guide with age, gender, HBV DNA, core promoter mutations and cirrhosis) and REACH-B (risk estimation for HCC in CHB) scores derived from Asian CHB patients were also accurate in treated patients. The PAGE-B (platelet, age, and gender-hepatitis B) score has persistently high predictability for treated Caucasian and Asian patients with different HCC risk profiles. |
| Publish Date |
2021-04-29 08:35 |
| Citation |
Guo J, Gao XS. Prediction models for the development of hepatocellular carcinoma in chronic hepatitis B patients. World J Clin Cases 2021; 9(14): 3238-3251 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i14/3238.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i14.3238 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
